How does age impact the diagnostic accuracy of the Spot Vision Screener in detecting amblyopia (lazy eye) risk factors or visual acuity (VA) impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The Spot Vision Screener's diagnostic performance in detecting amblyopia risk factors or poor visual acuity (VA) is significantly influenced by age, with varying sensitivity and specificity across different age groups. When examining the impact of age on the diagnostic performance of the Spot Vision Screener, it's crucial to consider the developmental stages of children's visual systems and their ability to cooperate during screening.

  • In younger children, particularly those under 3 years of age, the device may have lower sensitivity but higher specificity, as noted in the context of vision screening technologies 1.
  • As children grow older, from 3 to 6 years, the sensitivity of the Spot Vision Screener generally improves, maintaining good specificity, which makes it a more reliable tool for detecting potential vision problems in this age group. The age-related variation in the Spot Vision Screener's performance is attributed to the ongoing development of children's visual systems and the natural changes in refractive errors during early childhood, which can affect the accuracy of measurements.
  • The algorithms used by the Spot Vision Screener are calibrated to account for these developmental differences across various age groups. For optimal diagnostic outcomes, screening protocols should take into account these age-dependent performance characteristics of the Spot Vision Screener.
  • This might involve implementing more frequent screenings for very young children to compensate for the lower sensitivity in this age group, as suggested by the principles outlined in instrument-based pediatric vision screening policy statements 1. Understanding and adjusting for these age-related performance differences are essential for clinicians to interpret screening results accurately and to determine when additional comprehensive eye examinations are necessary.

From the Research

Age and Diagnostic Performance of the Spot Vision Screener

The diagnostic performance of the Spot Vision Screener in detecting amblyopia risk factors or poor visual acuity (VA) can be affected by the age of the subject.

  • Studies have shown that the Spot Vision Screener has good sensitivity and specificity in detecting amblyopia risk factors in children, especially at preschool ages 2.
  • A study published in 2017 found that the Spot Vision Screener had an overall sensitivity of 89.8% and a specificity of 70.4% in detecting amblyopia risk factors in children aged 6 months to 3 years 3.
  • Another study published in 2019 found that the overall sensitivity for the Spot Vision Screener was 87.7% and the specificity was 78.0% in detecting amblyopia risk factors in children, with higher sensitivity and specificity in preschool children (under 7 years old) 2.
  • The sensitivity and specificity of the Spot Vision Screener can vary depending on the referral criteria used, with some studies showing improved specificity with minimal impact on sensitivity when using updated referral criteria 4, 5.
  • A study published in 2020 found that the Spot Vision Screener had a sensitivity of 86.08% and a specificity of 90.15% in detecting amblyogenic risk factors in children aged 24 to 96 months, with areas under the curve of 0.906 for hyperopia, 0.887 for spherical equivalent, and 0.914 for astigmatism 5.
  • The performance of the Spot Vision Screener can also be affected by the age of the child, with some studies showing that it is more accurate in older children 3, 6.

Factors Affecting Diagnostic Performance

Several factors can affect the diagnostic performance of the Spot Vision Screener, including:

  • Age of the subject: The Spot Vision Screener has been shown to have better sensitivity and specificity in older children 3, 6.
  • Referral criteria: The sensitivity and specificity of the Spot Vision Screener can vary depending on the referral criteria used 4, 5.
  • Type of amblyopia risk factor: The Spot Vision Screener has been shown to have higher sensitivity and specificity for certain types of amblyopia risk factors, such as astigmatism and spherical equivalent 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnostic test accuracy of Spot and Plusoptix photoscreeners in detecting amblyogenic risk factors in children: a systemic review and meta-analysis.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2019

Research

Validation of Spot screening device for amblyopia risk factors.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2014

Research

Detection of Amblyogenic Refractive Error Using the Spot Vision Screener in Children.

Optometry and vision science : official publication of the American Academy of Optometry, 2020

Research

Performance of the Spot vision screener for the detection of amblyopia risk factors in children.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2014

Related Questions

What is known about the sensitivity of Spot (Autorefractor) in detecting hyperopia, amblyopia, or subtle bilateral blur?
What is the diagnostic accuracy (sensitivity, specificity) of the Spot Vision Screener for detecting amblyopia (lazy eye) risk factors in children under 4 years versus those 4 years and older?
Does visual acuity testing after Spot Vision Screener (SVS) reduce false positive referrals in children aged 4 and older?
What is the evidence that the Spot Vision Screener (SVS) over-refers for astigmatism and under-detects hyperopia, affecting referral accuracy for vision impairment?
What are the common characteristics of children who pass the Spot Vision (Visual Acuity) Screener but fail Visual Acuity (VA) testing?
What is the relationship between Bortezomib (Velcade) and hyperproteinemia?
What is the management of Femoroacetabular Impingement (Femoroacetabular Impingement) in the Emergency Department (ED)?
What is the evidence that the Spot Vision Screener (SVS) over-refers for astigmatism and under-detects hyperopia, affecting referral accuracy for vision impairment?
What are the treatment options for atrophic vaginitis?
Is a computed tomography (CT) scan necessary for diagnosing femoroacetabular impingement?
What is the management plan for a 46-year-old female with breast cancer, presenting with hypotension (blood pressure 90/50mmHg), who has undergone titration of norepinephrine (NorEpi) at 10 micrograms per minute and subsequently developed severe hypotension (blood pressure 80/40mmHg), tachycardia (heart rate 165), and received Atrovent (ipratropium bromide) nebulization?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.